Spring 2015

Witness to Infection

A new technique that allows scientists to watch as viruses enter cells could lead to improved therapies 

By Jacqueline Mitchell

Composed of little more than a few strands of genetic material and some proteins, viruses are barely alive. Yet the tiny microorganisms are among our deadliest foes. Now, a Tufts microbiologist is using new imaging techniques to find out how they make us sick.

James Munro, who joined the School of Medicine faculty last fall, was part of a team that pioneered the use of fluorescent molecules that act as tiny beacons and allow researchers to watch in real time as an HIV virus prepares to infect a cell. What the team saw, in discerning distances as small as a billionth of an inch, could lead to new treatments or vaccines for infectious viral diseases, such as HIV and Ebola.

Scientists already knew that certain viruses, including HIV, Ebola and influenza, use the proteins on their surfaces to infect host cells. The surface proteins function like skeleton keys: If they match the corresponding proteins on the host cell—think of them as the locks—the virus gains entry.

It’s by recognizing these viral proteins that your immune system remembers diseases you’ve been exposed to before. That’s why you won’t get the chicken pox or the same strain of the flu twice. Most vaccines are designed based on the structure of these surface molecules.

“They say that HIV makes every possible mutation every day.” —James Munro

But the surface proteins on HIV, which the World Health Organization says has killed 40 million people since the disease was identified in the early 1980s, have frustrated scientists for some 30 years. For one thing, the virus evolves too quickly for our immune systems or science to catch up—so far.

“They say that HIV makes every possible mutation every day,” says Munro, an assistant professor of molecular biology and microbiology at the Sackler School of Graduate Biomedical Sciences.

Beyond the virus’ continuous evolution, its surface protein is a remarkable shape-shifter, with the ability to change its three-dimensional structure in an origami-like process called molecular conformational dynamics, says Munro, who specializes in understanding how that happens. “The goal of my work is really to bring these structures to life,” he says.

High-powered scans of HIV reveal a spherical virus that looks like a pincushion. The virus uses the heads of those pins—the surface proteins—to glom onto and fuse with T cells in the immune system.

In experiments reported in the journals Science and Nature in October 2014, Munro and his colleagues zoomed in on those protrusions, each made up of a long protein molecule covered in sugars, known as a glycoprotein. The team was led by Munro’s postdoctoral advisor, Walther Mothes of Yale University School of Medicine, as well as his former graduate advisor, Scott Blanchard at the Weill Cornell Medical College.

The researchers knew that the HIV surface protein underwent its origami act to match its intended target at the moment of infection. That allowed the glycoprotein key to unlatch the T cells’ locks—a surface protein known as CD4—and gain entrance to the body. But they didn’t know what triggered the transformation.

Conventional wisdom, says Munro, held that the protein transformed itself in response to something else in the environment—the presence of another molecule or cell, for example, or a change in temperature, salinity or pressure.

Using high-resolution cameras and high-powered computing, the team found that the HIV protein was, in fact, always in motion, cycling through different shapes, much like a person moving through a series of yoga poses.

This surprising result, which paints a far more detailed portrait of this enigmatic molecule, could one day produce a way to disable HIV and other viruses.

Jacqueline Mitchell can be reached at jacqueline.mitchell@tufts.edu.

Top Stories

On Fighting Ebola

Alumna Nahid Bhadelia takes a big-picture approach to stemming the spread of disease

Son of Confucius

This junior faculty member in neuroscience is a proud descendant of the ancient Chinese sage

The Awkward Fit

Geographically, culturally and politically, Maine lobstermen have some distance to go if they are ever going to connect with better health care

The Mercy Ship

Born from a wish to improve the lives of Boston’s poor, sickly children by exposing them to fresh air, the original Floating Hospital quickly created new and better forms of pediatric medicine

Heads Together

Veterinarians and physicians confer to help deliver a knockout blow to the cancers their patients share

Editor's Picks

Dockside Medicine

Born into a lobstering family, I worry about their well-being in a special way 

Less Salt, Live Longer

Study finds too much sodium a worldwide killer

Nanoscale Cancer

Igor Sokolov’s research could yield better ways to identify and track malignant cells early on

On Designer Babies

Genetic enhancement of human embryos is not a practice for civil societies

Our Ailing Patient

U.S. medicine is not delivering the value it should, says Rishi Manchanda, who offers a prescription for the future

Spin Doctors

Hospital websites give unbalanced medical information, according to a systematic survey of 262 institutions